PCI Pharma Services
The Director, QC & Microbiology provides strategic and operational leadership for the site’s Quality Control Chemistry and Microbiology functions, ensuring scientific excellence, regulatory compliance, and laboratory capacity to support current operations and future growth. This role oversees laboratory performance, testing, investigations, and continuous improvement while partnering with cross‑functional teams and representing QC during inspections and audits.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
1001-5000 employees
PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success.
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala
Jul 14, 2025
PCI Pharma Services completes acquisition of Ajinomoto Althea
Aug 28, 2025
PCI Pharma Services Receives Strategic Investment from Bain Capital, Kohlberg and Mubadala
Sep 11, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PCI Pharma Services.
13% below the average for this role
Northeast Philadelphia’s PCI Pharma Services Receives Massive Investment, Now Valued At $10B
Jul 23, 2025
QC Analytical/Microbiology Lead
No deviation
Supervisor, QC Microbiology Laboratory
Integra LifeSciences
Principal Scientist, GMP QC Microbiology
Eli Lilly and Company
QC Technical Specialist (Microbiology)
AstraZeneca
QC Microbiology Lead
Arthur M. Blank Family of Businesses
QC Microbiology Team Leader
City of Winnipeg